⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2379812 | 0.65 | — | — | |
| SCHEMBL3937275 | 0.59 | — | — | |
| SCHEMBL71949 | 0.58 | — | — | |
| SCHEMBL3650449 | 0.58 | — | — | |
| SCHEMBL3934761 | 0.56 | — | — | |
| SCHEMBL3935716 | 0.56 | — | — | |
| SCHEMBL219313 | 0.56 | — | — | |
| SCHEMBL4067151 | 0.55 | — | — | |
| SCHEMBL17265830 | 0.52 | — | — | |
| SCHEMBL1401089 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6667306-B1 | Aminobenzothiazole and aminobenzoxazole derivatives; thrombosis | MILLENNIUM PHARMACEUTICALS, INC. | 2003-12-23 | — | — | US | disclosed |
| EP-1047699-A1 | PLATELET ADP RECEPTOR INHIBITORS | COR THERAPEUTICS, INC. (US) | 2000-11-02 | — | — | EP | disclosed |
| WO-1999036425-A1 | PLATELET ADP RECEPTOR INHIBITORS | COR THERAPEUTICS, INC. (US) | 1999-07-22 | — | — | WO | disclosed |